Subject: PositiveID’s ExcitePCR CSO Discusses Growing Markets for their Family of Products

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PositiveID’s ExcitePCR CSO Discusses Growing Markets for their Family of Products
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (Pink Sheets: PSID)


Price: 0.01

Change (%): - 0.001 (6.25)

Volume: 632,482
PSID Chart

PositiveID’s ExcitePCR Proposes Use of its FireflyDX to Address Food Safety Testing Needs Revealed in Blue Ribbon Study Panel on Defense of Animal Agriculture in Interview with

ExcitePCR Chief Science Officer Kimothy Smith, DVM, Ph.D. discusses utilizing ExcitePCR’s FireflyDX Products to Improve Pathogen and GMO Testing for the $19 Billion Global Food Safety Testing Market

AUSTIN, Texas, Oct. 26, 2017 (GLOBE NEWSWIRE) -, Inc. and PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, today announced a new audio interview with Kimothy Smith, DVM, Ph.D., Chief Science Officer of PositiveID’s ExcitePCR subsidiary. In the interview, Smith discusses the recently released “Blue Ribbon Study Panel on Biodefense: Defense of Animal Agriculture,” and describes how ExcitePCR’s FireflyDX™ products could help address the needs of the 19 billion dollar global food safety testing market. The interview can be heard at:

As highlighted in a recently published “Blue Ribbon Study Panel on Biodefense: Defense of Animal Agriculture,” “The increasing rate of emerging and reemerging zoonotic disease, along with threats and attempts by those with nefarious intent to attack food and agriculture, point to the need to exert more effort to eliminate vulnerabilities and reduce consequences associated with America’s agricultural sector.” Smith explains that FireflyDX will have applications to food safety and agricultural defense, among others, and could be used pen-side by veterinarians and animal health technicians diagnosing routine infectious diseases or during a severe outbreak of disease whether naturally occurring or as a result of agro-terrorism.

The FireflyDX products, currently under development, include the FireflyDX-Portable™ and FireflyDX-Handheld™, and are designed for use in markets where molecular diagnostics are critical to ensure rapid safety and treatment protocols. FireflyDX has already proven its ability in the lab to detect various pathogens that are a threat to food safety including common food contaminants such as E. coli O157, animal diseases caused from Anthrax, Plague, and Brucellosis, and a genetically modified organism (GMO) biomarker, which is critical to the corn and soybean export markets.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks